CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
OxyPrem develops a specialized brain oximeter for preterm infants to monitor oxygen levels accurately. This device addresses the critical need for precise oxygen therapy in vulnerable newborns, significantly reducing the risk of brain damage and improving neonatal care outcomes.
Globally, 15 million preterm babies are born annually (435,000 in Europe), from which 1 million die.
Even when surviving, they may face disabilities, such as neurodevelopment impairment or paralysis.
Since their respiratory and cardiovascular systems are immature, they need early oxygen (O2) therapy.
Tissue oximeters are medical devices needed to monitor the actual level of O2 supply in their brain, since little O2 variations can produce irreversible damage.
However, current devices are adapted…
OXYPREM AG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
